Ameriabank attracts USD 11.5 million in funding from Symbiotics - News | Ameriabank
My Ameria
ՆՈՐ
Մոբայլ բանկինգ
26Feb

Ameriabank attracts USD 11.5 million in funding from Symbiotics

26 Feb, 2018 | Press release, All | Return|

Ameriabank and the "Symbiotix" organization sign a main loan agreement of 11.5 million US dollars within the framework of the bond program intended for the financing of micro, small and medium enterprises of Symbiotix, with the possibility of increasing the amount of financing by an amount equivalent to another 10 million US dollars in freely convertible currency or AMD. Credit funds are aimed at financing micro, small and medium enterprises that are clients of Ameriabank.

Artak Hanesyan, the chairman-general director of Ameriabank's Directorate, noted. "It is with great pleasure that we announce the launch of a new financing program for micro, small and medium enterprises. Financing of SMEs is one of Ameriabank's primary strategic directions. We are happy to acquire a new partner in the form of Symbiotics, with whom we are signing the first contract, expecting to develop mutually beneficial cooperation in the future."

Daniel Schreiber, Chief Investment Officer of Symbiotics, said: "We are also happy to establish a partnership with such a prestigious and innovative organization as Ameriabank. We expect valuable cooperation, within the framework of which we will direct our efforts to the development of micro, small and medium enterprises in Armenia."

About symbiotics

"Symbiotics" investment organization was founded in 2004. in Geneva. Specializes in financing for developing countries and sustainable development, as well as providing inclusive financing. The company also provides market research, investment advisory and asset management services. As an asset manager within collective investment schemes, it is subject to the regulations of the Swiss Financial Markets Regulatory Authority and is licensed by the FCA (Financial Conduct Authority, UK). Symbiotics has a staff of over 130 professionals and offices in London, Amsterdam, Zurich, Cape Town, Mexico City and Singapore. Headquartered in Geneva. Since its inception, Symbiotics has invested more than USD 4 billion in approximately 375 microfinance organizations in 68 developing countries, partnering with 44 investment funds and numerous institutional investors.